ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MVASI, KANJINTI Now Available in United States americanpharmaceuticalreview
July 22, 2019Amgen and Allergan announced that MVASI? (bevacizumab-awwb), a biosimilar to Avastin? (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin? (trastuzumab), are now available in the United States. -
FDA Approves KANJINTI americanpharmaceuticalreview
June 20, 2019Amgen and Allergan announced the U.S. Food and Drug Administration (FDA) has approved KANJINTI? (trastuzumab-anns) for all approved indications of the reference product ... -
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin drugs
June 17, 2019FDA Approves Kanjinti.
Pharma Sources Insight January 2025
